Cargando…
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry
BACKGROUND: Unlike malignant primary central nervous system (CNS) tumours outcome data on non-malignant CNS tumours are scarce. For patients diagnosed from 1996 to 2002 5-year relative survival of only 85.0% has been reported. We investigated this rate in a contemporary patient cohort to update info...
Autores principales: | Woehrer, A, Hackl, M, Waldhör, T, Weis, S, Pichler, J, Olschowski, A, Buchroithner, J, Maier, H, Stockhammer, G, Thomé, C, Haybaeck, J, Payer, F, von Campe, G, Kiefer, A, Würtz, F, Vince, G H, Sedivy, R, Oberndorfer, S, Marhold, F, Bordihn, K, Stiglbauer, W, Gruber-Mösenbacher, U, Bauer, R, Feichtinger, J, Reiner-Concin, A, Grisold, W, Marosi, C, Preusser, M, Dieckmann, K, Slavc, I, Gatterbauer, B, Widhalm, G, Haberler, C, Hainfellner, J A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899758/ https://www.ncbi.nlm.nih.gov/pubmed/24253501 http://dx.doi.org/10.1038/bjc.2013.714 |
Ejemplares similares
-
Clinical neuropathology practice guide 1-2013: Molecular subtyping of glioblastoma: ready for clinical use?
por: Woehrer, Adelheid, et al.
Publicado: (2013) -
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
por: Heugenhauser, Johanna, et al.
Publicado: (2022) -
The Digital Brain Tumour Atlas, an open histopathology resource
por: Roetzer-Pejrimovsky, Thomas, et al.
Publicado: (2022) -
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
por: Buchroithner, Johanna, et al.
Publicado: (2018) -
Teaching Case 2-2018: Sclerosing myxopapillary ependymoma mimicking whorling-sclerosing meningioma
por: Lang, Julia, et al.
Publicado: (2018)